Navigation Links
Pfizer Wins CIO 100 Award for Patient Enrollment Optimization Solution From DecisionView
Date:7/27/2010

business value by innovating with technology. The judges evaluated the applications according to two criteria: innovation and business value. CIO 100 winners had to demonstrate that they not only were able to create new value using IT and executed their project well, but also did so in uncommon, innovative ways:

  • pioneering a new technology,
  • applying a familiar technology to a new purpose,
  • setting the bar higher for their competitors.

ABOUT DECISIONVIEW

DecisionView develops innovative web-based software solutions that enable life sciences organizations around the world to improve clinical trial performance. DecisionView's flagship solution, StudyOptimizer, helps organizations optimize clinical trial enrollment by aggregating patient recruitment data from multiple sources and providing analytics, visualizations, and predictive scenario modeling that delivers unique and actionable insight. StudyOptimizer is used by four of the top ten global pharmaceutical companies, and has been used on over 750 clinical studies with over 120,000 subjects enrolled in over ten different therapeutic areas. Primary investors in the company include Granite Ventures and Aeris Capital. For additional information about DecisionView, go to www.decisionview.com or call 415-538-1800.


'/>"/>
SOURCE DecisionView Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pfizer Announces EMPHASIS-HF Trial to Halt Recruitment due to Significant Benefit Observed in Patients Treated With Inspra® (Eplerenone)
2. Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish
3. Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors
4. Pfizer Global Manufacturing Announces Plans to Reconfigure Its Global Plant Network
5. Anavex comments on failure of Pfizer and Medivations Alzheimers investigational drug Dimebon during Phase 3 clinical trials
6. Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting
7. Pfizer Global R&D Presents 2008 Top Intermediates CMO Award to Asymchem
8. GSK and Pfizer Innovative Agreement Creates Specialist HIV Company
9. Lakewood-Amedex, Inc. Appoints William J. Robison, Former Executive Vice President of Pfizer, as Board Member
10. MannKind Agrees with Pfizer on the Purchase of Frankfurt Insulin Manufacturing Plant
11. JMAR Technologies' Chief Scientist Invited by Pfizer Inc. to Speak at IFPAC -- BioSentry Makes Strides in Pharma Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ - iCo Therapeutics ... today reported financial results for the six months ... are expressed in Canadian dollars and presented under ... Quarter 2014 Highlights , Announced top-line ... (VA) primary endpoint for subjects enrolled in the ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Due to a ... last week, the Adult Stem Cell Technology Center, LLC ( ... support stem cell therapy research that might benefit ALS patients. ... cells for new stem cell technologies and therapeutic applications, FRC ... Ice Bucket Challenge donors who wish not to support ...
(Date:8/28/2014)... USA (PRWEB) August 28, 2014 SPIE ... of Physics and Optical Science and Director of the ... of North Carolina at Charlotte, and co-founder and Chairman ... to serve as the 2015 Vice President of SPIE, ... 2014 President Philip Stahl announced recent election results at ...
(Date:8/28/2014)... 28, 2014 “This kit has an improved ... from 0 to 150 ppb,” said Mark Tess, PhD, Mycotoxin ... benefit to plant owners and USDA-GIPSA inspection agencies that have ... Testing can take place in a matter of minutes with ... plant test the feed and grain before accepting it, but ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3Glenn Boreman, UNC Professor and Plasmonics Co-Founder, Elected to SPIE Presidential Chain 2
... CORVALLIS, Ore. Inkjet printers, a low-cost technology that in ... soon offer similar benefits for the future of solar energy. ... for the first time to create successful "CIGS" solar devices ... by 90 percent and will significantly lower the cost of ...
... HumanTouch, LLC welcomes David Meyer to our team as the ... tasked with assisting the executive leadership in building upon the ... health Information technology (IT) experience and expertise HumanTouch has been ... Senior Executive with more than 20 years of diverse experience ...
... ANGELES, June 28, 2011 Genesis Biopharma, Inc. ... therapies, is holding a conference call with the ... Noon Eastern (9:00 a.m. Pacific).  The Company,s Chairman ... provide an update on the business, and discuss ...
Cached Biology Technology:Inkjet printing could change the face of solar energy industry 2HumanTouch Welcomes David Meyer as Vice President of HumanTouch's new Health Solutions Division 2Genesis Biopharma Conference Call and Webcast Reminder 2
(Date:9/2/2014)... touch a hot oven, you rapidly pull your hand ... in sensing and responding to such painful stimuli, they ... researchers have made a surprising discovery about the role ... and have built a structural model of the molecule. ... , may help direct new strategies to treat pain ...
(Date:9/1/2014)... amount of research shows an association between TV viewing ... Now, a new Cornell University study points out that ... lead people to eat twice as much as other ... movie while snacking your mouth will see more action ... new article just published in the Journal of ...
(Date:9/1/2014)... quality of the U.S. diet showed some modest improvement ... a reduction in the consumption of unhealthy trans fats, ... the rich and the poor. , , An unhealthy ... some cancers. Eating a healthy diet is an important ... Evaluating population trends in diet quality is important because ...
Breaking Biology News(10 mins):Surprising new role for calcium in sensing pain 2Surprising new role for calcium in sensing pain 3Can action movies make you fat? 2Quality of US diet improves, gap widens for quality between rich and poor 2Quality of US diet improves, gap widens for quality between rich and poor 3
... and Washington DC (July 27, 2009) According to a ... Making , a large-scale, covert anthrax attack on a ... extremely effective public health response, primarily because of expected ... to it. The article "Predicting Hospital Surge after ...
... overall nation-wide estimate of the tiger population brought a ... by the Nepal Government,s Department of National Parks and ... 194) breeding tigers in the wild within the ... estimate was jointly implemented by the DNPWC, Department of ...
... Atrophy is the second-leading cause of infant mortality in the ... Iowa State University,s College of Veterinary Medicine, would like to ... slide off the list altogether. , Most Spinal Muscular Atrophy ... or deleted gene called Survival Motor Neuron 1 (SMN1) that ...
Cached Biology News:Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 2121 breeding tigers estimated to be found in Nepal 2ISU researchers find possible treatment for spinal muscular atrophy 2
Request Info...
Anti-ZFP200 Family: Zinc Finger Peptide Sequence: CGKSFNHKTNLNKHER...
Donor feline serum and plasma...
Collected from sexually mature, mixed sex, mixed breed cats. Physiochemical constituents are measured to ensure lot-to-lot consistency....
Biology Products: